Fingerprint
Dive into the research topics of 'Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities
Rozalina G. McCoy, Holly K. Van Houten, Pinar Karaca-Mandic, Joseph S. Ross, Victor M. Montori, Nilay D. Shah
Research output: Contribution to journal › Article › peer-review